These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11348484)

  • 41. The effects of dose and diet on the pharmacokinetics of omeprazole in the horse.
    Sykes BW; Underwood C; McGowan CM; Mills PC
    J Vet Pharmacol Ther; 2017 Apr; 40(2):172-178. PubMed ID: 27478135
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Helicobacter pylori and nonsteroidal anti-inflammatory drugs: interaction with proton pump inhibitor therapy for prevention of nonsteroidal anti-inflammatory drug ulcers and ulcer complications--future research needs.
    Graham DY
    Am J Med; 2001 Jan; 110(1A):58S-61S. PubMed ID: 11166000
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acute effects of ranitidine, famotidine and omeprazole on plasma gastrin in the rat.
    Decktor DL; Pendleton RG; Kellner AT; Davis MA
    J Pharmacol Exp Ther; 1989 Apr; 249(1):1-5. PubMed ID: 2565384
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of repeated injection and continuous infusion of omeprazole and ranitidine on intragastric pH over 72 hours.
    Netzer P; Gaia C; Sandoz M; Huluk T; Gut A; Halter F; Hüsler J; Inauen W
    Am J Gastroenterol; 1999 Feb; 94(2):351-7. PubMed ID: 10022628
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetic and pharmacodynamic interactions between omeprazole and amoxycillin in Helicobacter pylori-positive healthy subjects.
    Pommerien W; Braun M; Idström JP; Wrangstadh M; Londong W
    Aliment Pharmacol Ther; 1996 Jun; 10(3):295-301. PubMed ID: 8791954
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
    Hatlebakk JG; Berstad A
    Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative pharmacokinetic/pharmacodynamic study of proton pump inhibitors, omeprazole and lansoprazole in rats.
    Katashima M; Yamamoto K; Sugiura M; Sawada Y; Iga T
    Drug Metab Dispos; 1995 Jul; 23(7):718-23. PubMed ID: 7587960
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacokinetics and pharmacodynamics of butorphanol in llamas after intravenous and intramuscular administration.
    Carroll GL; Boothe DM; Hartsfield SM; Martinez EA; Spann AC; Hernandez A
    J Am Vet Med Assoc; 2001 Nov; 219(9):1263-7. PubMed ID: 11697372
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Use of Point-of-Care Gastric pH Testing to Assess the Efficacy of Acid Suppression Therapy in the Neonatal Intensive Care Unit.
    Ekhaguere OA; Padula MA; Jensen EA
    Am J Perinatol; 2020 Mar; 37(4):415-420. PubMed ID: 30780184
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetics and pharmacodynamics of lansoprazole in children with gastroesophageal reflux disease.
    Gremse D; Winter H; Tolia V; Gunasekaran T; Pan WJ; Karol M; Chiu YL; Pilmer B; Book L
    J Pediatr Gastroenterol Nutr; 2002; 35 Suppl 4():S319-26. PubMed ID: 12607792
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Acute injury to the gastric mucosa by acetylsalicylic acid. A comparative endoscopic study in man with oral prostaglandin analogs, omeprazole and ranitidine].
    Müller P; Dammann HG; Simon B
    Arzneimittelforschung; 1986 Feb; 36(2):265-8. PubMed ID: 3083829
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of single-dose intravenous omeprazole and ranitidine on gastric pH during general anesthesia.
    Atanassoff PG; Alon E; Pasch T
    Anesth Analg; 1992 Jul; 75(1):95-8. PubMed ID: 1616168
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of cimetidine and ranitidine on pharmacokinetics and pharmacodynamics of a single dose of dofetilide.
    Abel S; Nichols DJ; Brearley CJ; Eve MD
    Br J Clin Pharmacol; 2000 Jan; 49(1):64-71. PubMed ID: 10606839
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Omeprazole disposition in children following single-dose administration.
    Kearns GL; Andersson T; James LP; Gaedigk A; Kraynak RA; Abdel-Rahman SM; Ramabadran K; van den Anker JN
    J Clin Pharmacol; 2003 Aug; 43(8):840-8. PubMed ID: 12953341
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of parenteral omeprazole and ranitidine on gastric pH and the outcome of bleeding peptic ulcer.
    Lanas A; Artal A; Blás JM; Arroyo MT; Lopez-Zaborras J; Sáinz R
    J Clin Gastroenterol; 1995 Sep; 21(2):103-6. PubMed ID: 8583073
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Age-related differences in the pharmacokinetics and pharmacodynamics of lansoprazole.
    Hussein Z; Granneman GR; Mukherjee D; Samara E; Hogan DL; Koss MA; Isenberg JI
    Br J Clin Pharmacol; 1993 Nov; 36(5):391-8. PubMed ID: 12959285
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Omeprazole, ranitidine, and cimetidine have no effect on peak blood ethanol concentrations, first pass metabolism or area under the time-ethanol curve under 'real-life' drinking conditions.
    Brown AS; James OF
    Aliment Pharmacol Ther; 1998 Feb; 12(2):141-5. PubMed ID: 9692688
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rapid effect of lansoprazole on intragastric pH: a crossover comparison with omeprazole.
    Thoring M; Hedenström H; Eriksson LS
    Scand J Gastroenterol; 1999 Apr; 34(4):341-5. PubMed ID: 10365892
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Omeprazole promotes proximal duodenal mucosal bicarbonate secretion in humans.
    Mertz-Nielsen A; Hillingsø J; Bukhave K; Rask-Madsen J
    Gut; 1996 Jan; 38(1):6-10. PubMed ID: 8566861
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacodynamic modeling of lansoprazole using an indirect irreversible response model.
    Puchalski TA; Krzyzanski W; Blum RA; Jusko WJ
    J Clin Pharmacol; 2001 Mar; 41(3):251-8. PubMed ID: 11269565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.